Inpharmus

Inpharmus İnovatif çözümleri sağlıkla buluşturuyoruz!

Developing drugs for rare diseases is challenging: small patient populations, limited data, and high R&D costs. Orphan d...
12/02/2026

Developing drugs for rare diseases is challenging: small patient populations, limited data, and high R&D costs. Orphan drugs help overcome these hurdles and address unmet medical needs. Inpharmus focuses on patient-centric solutions grounded in scientific evidence.

Chemotherapy is a cornerstone of oncology treatment; however, its side effects can challenge patients’ quality of life a...
09/02/2026

Chemotherapy is a cornerstone of oncology treatment; however, its side effects can challenge patients’ quality of life and treatment adherence.

Supportive approaches used alongside chemotherapy and under physician supervision aim to help patients cope with the challenges encountered during the treatment process.

A holistic approach in oncology focuses not only on treatment protocols, but also on the patient’s entire journey, placing safety and standards of care at its core.

Guided by scientific evidence, Inpharmus develops patient-centered solutions that prioritize patient safety and standards of care within the oncology care pathway.

In the fight against cancer, awareness, the importance of early detection, and scientific progress gain meaning when add...
04/02/2026

In the fight against cancer, awareness, the importance of early detection, and scientific progress gain meaning when addressed together. Creating sustainable impact in this field requires acting with responsibility and guided by science.

At Inpharmus, we contribute to the healthcare ecosystem through a science-based approach while supporting the advancement of accurate information and awareness around cancer.

30/01/2026

Our Türkiye Medical Director, Mehmet Apaydın, shares Inpharmus’ medical roadmap for 2026, focusing on data-driven science, clinical impact, and strong MSL partnerships.

20/01/2026

During our field sales meeting in Adana, we spoke with Batuhan Özenç about our 2026 vision and our “Leave a mark on the future” approach. In this interview, he also explains why this year is critical for us, our strategic priorities, and how we are steering toward our goals.

As we take the first steps on our 2030 Unicorn journey, this perspective strengthens both our team’s motivation and our roadmap.

16/01/2026

Between January 6-9, 2026, we came together with our teams in Adana for our field sales meeting.

Over the course of these four days, we had the opportunity to listen closely to on-the-ground experiences while collectively reviewing our goals, priorities, and roadmap. Alongside the intensive meetings, moments that strengthened our team spirit were also an essential part of this gathering.

It was a highly productive and motivating meeting for us, reminding us once again of the value of being a team that is driven by the field, creates together, and grows stronger together. We would like to thank all our team members who contributed to this process.

31/12/2025

As we step into a new year, guided by science, continuing to produce and create value with the same sense of responsibility.

Here’s to many more years together.

#2026

Epigenetics studies how our environment and lifestyle influence our genes by changing the chemicals attached to them. Wh...
24/12/2025

Epigenetics studies how our environment and lifestyle influence our genes by changing the chemicals attached to them. What we eat, our physical activity, and other factors can modify these chemical tags, shaping our health.

Certain genetic mutations increase cancer risk. Likewise, some epigenetic changes can raise cancer risk. Differences in DNA methylation can help determine cancer types or detect hard-to-find cancers earlier.

Unlike genetic mutations, epigenetic changes are reversible and can be modified with certain drugs.

Start exploring more about epigenetic changes and cancer risk.

22/12/2025

Every patient could have a rare disease. Listen carefully, consider all possibilities, and help break the diagnostic odyssey. Early recognition saves lives. 💙

Cancer is one of the leading global health challenges, and about half of all cancers are diagnosed at an advanced stage....
16/12/2025

Cancer is one of the leading global health challenges, and about half of all cancers are diagnosed at an advanced stage. Early detection can extend life expectancy, reduce treatment-related side effects, and improve quality of life. Timely intervention allows for less invasive treatments and more effective disease management.

Paying attention to symptoms and keeping up with regular health check-ups can save lives. Raise awareness and prioritize your health. 💙

A new protein that forms on cancer cells when certain mutations occur in tumor DNA. Neoantigens may play an important ro...
12/12/2025

A new protein that forms on cancer cells when certain mutations occur in tumor DNA. Neoantigens may play an important role in helping the body make an immune response against cancer cells. Neoantigens used in vaccines and other types of immunotherapy are being studied in the treatment of many types of cancer.

SCID (Severe Combined Immunodeficiency) may not cause any noticeable symptoms. If signs do appear, they usually include:...
09/12/2025

SCID (Severe Combined Immunodeficiency) may not cause any noticeable symptoms.

If signs do appear, they usually include:

🔹 Your baby not gaining weight at a typical healthy rate 🔹 Chronic diarrhea 🔹 Frequent and severe infections

Your baby’s immune response to infections will be significantly weakened or completely absent. This means they are much more likely to get sick, and when they do, symptoms can be far more severe than normal.

Awareness and early diagnosis can save lives. 💙

Learn more in our latest blog post. 👉 https://www.inpharmus.com/blog/the-silent-threat-to-the-immune-system-what-you-need-to-know-about-scid

Address

Esentepe, Büyükdere Caddesi Kanyon Ofis Bloğu No: 185 Kat: 14, 34394 Levent/Şişli/Şişli/Istanbul
Istanbul
34000

Alerts

Be the first to know and let us send you an email when Inpharmus posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram